Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Soticlestat | 1429505-03-2 | 99.83% | 373.45 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY109123100MG

Encompass_Preferred

Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor with potential for epilepsy syndromes research.

  • It is for research use only, not intended for human use.
  • It inhibits the catalytic activity of human cholesterol 24-hydroxylase (CH24H) in a concentration-dependent manner with an IC50 of 4.5 nM.
  • Treatment with soticlestat lowers brain 24S-hydroxycholesterol in a dose-dependent manner.
  • It substantially reduces premature deaths of APP/PS1-Tg mice at a dose lowering brain 24S-hydroxycholesterol by approximately 50%.
  • It can suppress potassium-evoked extracellular glutamate elevations in the hippocampus.

Catalog No. 50-003-44346


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.